Split History
ETFs Holding SYBX »    SYBX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synlogic is a clinical-stage biopharmaceutical company focused on improving its proprietary drug discovery and development platform to create Synthetic Biotic™ medicines. Synthetic Biotic medicines are designed to be programmed to metabolize, or consume, a toxic substance, compensate for damaged metabolic pathways in patients, or produce one or more therapeutic factors. Co.'s primary product candidate for the treatment of metabolic dysfunction is SYNB1618, an oral therapy intended for the treatment of phenylketonuria. Co.'s Synthetic Biotic clinical immuno-oncology candidate is SYNB1891, a Synthetic Biotic medicine engineered to act as a dual innate and adaptive immune activator. According to our SYBX split history records, Synlogic has had 1 split.
SYBX split history picture
Synlogic (SYBX) has 1 split in our SYBX split history database. The split for SYBX took place on August 28, 2017. This was a 1 for 7 reverse split, meaning for each 7 shares of SYBX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.

When a company such as Synlogic conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SYBX split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Synlogic shares, starting with a $10,000 purchase of SYBX, presented on a split-history-adjusted basis factoring in the complete SYBX split history. SYBX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/30/2015
End date: 06/23/2021
Start price/share: $49.00
End price/share: $4.39
Dividends collected/share: $0.00
Total return: -91.04%
Average Annual Total Return: -34.34%
Starting investment: $10,000.00
Ending investment: $896.10
Years: 5.73
Date Ratio
08/28/20171 for 7
SYBX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SYK Split History
SYN Split History
TARO Split History
TBRA Split History
TCON Split History
TEAR Split History
TECH Split History
TELK Split History
TENX Split History
TEVA Split History

Also explore: SYBX shares outstanding history

Trisura Group Ltd. (TSU.CA)
BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SYBX Insider Buying

SYBX Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.